论文部分内容阅读
目的:观察并分析阿奇霉素序贯疗法治疗小儿支原体肺炎的临床疗效及安全性。方法:从该院2013年06月至2015年12月收治的支原体肺炎小儿患者中随机选取60例,依照患儿的就诊次序将其平均分为研究组与对照组各30例。对照组按照常规疗法进行治疗,研究组采取阿奇霉素序贯治疗方案,并于疗程结束后将两组患儿的治疗有效率、不良反应情况作比较。结果:研究组(96.7%)的治疗有效率要显著地高于对照组(66.7%,P<0.05)。研究组(6.7%)用药不良反应的发生率要明显低于对照组(26.7%,P<0.05)。结论:针对小儿支原体肺炎,应用阿奇霉素序贯治疗的疗效突出,且安全性高,值得临床借鉴和采纳。
Objective: To observe and analyze the clinical efficacy and safety of sequential treatment of azithromycin in children with mycoplasmal pneumonia. Methods: Sixty children were randomly selected from children with mycoplasma pneumonia admitted from June 2013 to December 2015 in our hospital. According to the order of treatment of the children, they were equally divided into study group and control group. The control group was treated according to the conventional therapy. The study group adopted the sequential treatment of azithromycin and the treatment efficiency and adverse reactions of the two groups were compared after the treatment. Results: The treatment efficiency of the study group (96.7%) was significantly higher than that of the control group (66.7%, P <0.05). The incidence of adverse drug reactions in the study group (6.7%) was significantly lower than that in the control group (26.7%, P <0.05). Conclusion: For children with mycoplasma pneumonia, application of azithromycin sequential treatment of outstanding efficacy, and high safety, it is worth learning and adoption.